ArticleDiscover oncology2025
Ropivacaine combined with esketamine in ultrasound-guided thoracic paravertebral nerve block in lung cancer patients undergoing thoracoscopic radical surgery.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Analgesic Efficacy of Different Doses of Esketamine as an Adjuvant to Ropivacaine for Thoracoscopy-Guided Thoracic Paravertebral Block After Thoracoscopic Radical Resection for Lung Cancer: A Prospective Randomized Controlled Trial.Drug design, development and therapy · 2026Trial
- The effect of esketamine as adjuvant to ropivacaine for unilateral paravertebral block on postoperative pain and sensitization in adult patients undergoing video-assisted thoracoscopic surgery: a randomized clinical trial.Journal of anesthesia · 2026Article
- Use of preoperative placement of mini-midline catheters in patients undergoing thoracoscopic lung resection.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe aim to evaluate the analgesic efficacy of ultrasound-guided thoracic paravertebral nerve block (TPVB) using ropivacaine combined with esketamine in lung cancer patients undergoing thoracoscopic radical surgery.
methodsThis retrospective study included clinical data from 74 lung cancer patients who underwent thoracoscopic radical surgery between January 2023 and June 2024. Patients were divided into two groups based on their analgesic regimen: the control group received standard general anesthesia, while the observation group received ultrasound-guided TPVB with ropivacaine combined with esketamine. General clinical parameters, changes in mean arterial pressure (MAP) and heart rate (HR), postoperative pain scores, serum pain mediator levels, time to awakening, time to mobilization, and duration of hospitalization, and incidence of adverse reactions were compared in two groups.
resultsThere were no significant differences between the two groups in terms of operation time, intraoperative bleeding, or dosages of sufentanil and remifentanil. Compared to the control group, the observation group showed lower MAP and HR at the completion of the operation. Additionally, Visual Analog Scale scores and serum levels of Neuropeptide Y, Substance P, and dopamine were also lower in the observation group. The postoperative time to awakening, time to mobilization, and duration of hospitalization were shorter in the observation group. No significant differences were observed in the incidence of adverse reactions between the two groups.
conclusionUltrasound-guided TPVB with ropivacaine and esketamine provides superior postoperative analgesia in lung cancer patients undergoing thoracoscopic radical surgery. This approach effectively reduces physiological stress responses, promotes faster recovery, and does not increase the risk of adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.